CTLA4 and melanoma: By targeting CTLA-4 to dramatically increase the detection of its two isoforms, we observed that melanoma-infiltrating and CAR-T cells had the highest expression level of the membranous variant, while circulating T cells in AML bone marrow and peripheral blood of melanoma patients expressed more soluble CTLA-4 (Fig. 8d–f).